Table 4.
Major remaining research problems and questions.
| 1 | International standard for (gene-specific) DBP and reference method for the measurement of DBP |
| 2 | Validation of measurement of free 25OHD and its potential clinical value in comparison with total 25OHD |
| 3 | Validation of measurement or calculation of free 1,25(OH)2D and its potential physiologic and clinical implications |
| 4 | Understanding of the environmental drive (and health implications) for the world-wide gene polymorphism of DBP/GC |
| 5 | Full understanding of the implications of actin-DBP binding in health and diseases |
| 6 | Understanding of the role of DBP in inflammation |
| 7 | Role of megalin and DBP-25OHD uptake, if any, in non-renal cells |